Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand

بواسطة Maria Domenica Cappellini, Antonis Kattamis, Vip Viprakasit, Pranee Sutcharitchan, Joseph Pariseau, Abderrahmane Laadem, Valerie Jessent-Ciaravino, Ali Taher
منشور في 2020

Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development

بواسطة John Porter, Ali Taher, Vip Viprakasit, Antonis Kattamis, Thomas D. Coates, Maciej Garbowski, Franz Dürrenberger, Vania Manolova, Frank Richard, M. Domenica Cappellini
منشور في 2022

A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia

بواسطة Suthat Fucharoen, Adlette Inati, Noppadol Siritanaratku, Swee L. Thein, William C. Wargin, Suzanne Koussa, Ali Taher, Nattawara Chaneim, Michael Boosalis, Ronald Berenson, Susan P. Perrine
منشور في 2018

Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions

بواسطة Helene Puehringer, Hossein Najmabadi, Hai Yang Law, Walter Krugluger, Vip Viprakasit, Serge Pissard, Erol Baysal, Ali Taher, Chantal Farra, Amein Al-Ali, Suad Al-Ateeq, Christian Oberkanins
منشور في 2018

Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO ^© )

بواسطة Ali Taher, Maria Domenica Cappellini, Vip Viprakasit, Pranee Sutcharitchan, Dalia Mahmoud, Abderrahmane Laadem, Anzalee Khan, Chad Gwaltney, Gale Harding, Kenneth Attie, Xiaosha Zhang, Jun Zou, Joseph Pariseau, X. Henry Hu, Antonis Kattamis
منشور في 2020

Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO ^© )

بواسطة Ali Taher, Vip Viprakasit, Maria Domenica Cappellini, Pranee Sutcharitchan, Richard Ward, Dalia Mahmoud, Abderrahmane Laadem, Anzalee Khan, Chad Gwaltney, Gale Harding, Kenneth Attie, Xiaosha Zhang, Jun Zou, Joseph Pariseau, X. Henry Hu, Antonis Kattamis
منشور في 2020

Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major

بواسطة Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi Kong Li, Vip Viprakasit, Mohsen S. Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Ali Taher
منشور في 2018

Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

بواسطة Dudley J. Pennell, John B. Porter, Maria Domenica Cappellini, Lee Lee Chan, Amal El-Beshlawy, Yesim Aydinok, Hishamshah Ibrahim, Chi Kong Li, Vip Viprakasit, Mohsen Saleh Elalfy, Antonis Kattamis, Gillian Smith, Dany Habr, Gabor Domokos, Bernard Roubert, Ali Taher
منشور في 2018

Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

بواسطة Maria Domenica Cappellini, John Porter, Amal El-Beshlawy, Chi Kong Li, John F. Seymour, Mohsen Elalfy, Norbert Gattermann, Stéphane Giraudier, Jong Wook Lee, Lee Lee Chan, Kai Hsin Lin, Christian Rose, Ali Taher, Swee Lay Thein, Vip Viprakasit, Dany Habr, Gabor Domokos, Bernard Roubert, Antonis Kattamis
منشور في 2018